CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Gilead Sciences›
Library
Gilead Sciences logo

Gilead Sciences

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

Foster City, CA, US🇺🇸
Founded
1987
Loading
Overview
M & A
Compare
Fundraising
Employees
Library

Gilead Sciences - Library

gilead.com·Crawled Oct 16, 2026·

Topics

Publication type

Content origin
Row density

Press

12 pages
  1. 48 Week Data Compare Viread to Stavudine When Used as Part of Patients First Anti HIV Regimen Data Presented at XIV International AIDS Conference in Barcelona/news/news-details/2002/48-week-data-compare-viread-to-stavudine-when-used-as-part-of-patients-first-anti-hiv-regimen-data-presented-at-xiv-international-aids-conference-in-barcelona
  2. 96 Week Data From Phase III Study Show Long Term Efficacy With Reduced Risk of Lipid and Metabolic Changes for Viread Versus Stavudine in Treatment Naive HIV Patients/news/news-details/2003/96-week-data-from-phase-iii-study-show-long-term-efficacy-with-reduced-risk-of-lipid-and-metabolic-changes-for-viread-versus-stavudine-in-treatment-naive-hiv-patients
  3. FDA Grants Marketing Clearance of Gileads VISTIDE for the Treatment of CMV Retinitis in Patients with AIDS/news/news-details/1996/fda-grants-marketing-clearance-of-gileads-vistide-for-the-treatment-of-cmv-retinitis-in-patients-with-aids
  4. Gilead Initiates Study 934 a 48 Week Clinical Trial Evaluating Viread and Emtriva versus Combivir/news/news-details/2003/gilead-initiates-study-934-a-48-week-clinical-trial-evaluating-viread-and-emtriva-versus-combivir

Careers & Hiring

7 pages
  1. Careers/careers

    Gilead, a global biopharma co. pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact.

  2. CORRECTING and REPLACING Gilead Sciences to Present at the Banc of America Securities 2004 Healthcare Conference on Friday May 21st/news/news-details/2004/correcting-and-replacing-gilead-sciences-to-present-at-the-banc-of-america-securities-2004-healthcare-conference-on-friday-may-21st
  3. Gilead Sciences: Early career opportunities/careers/opportunities/early-career-opportunities

    Gilead Sciences offers career pathways for early career professionals, including full-time entry level jobs for recent graduates, internships and postdoctoral fellowships.

  4. Gilead Sciences: Global workforce/careers/global-workforce

    Gilead Sciences offers global career opportunities across offer opportunities North, Central and South America, Europe, the UK, the Middle East, Africa and Asia Pacific.

Team

3 pages
  1. Board of Directors/company/board-of-directors

    The page describes Gilead's board of directors.

  2. Gilead Sciences Board of directors/company/board-governance-and-committees

    Access biographical information about members of the Gilead Sciences Board of Directors.

  3. Leadership/company/leadership

    The page describes Gilead's leadership team.

About

3 pages
  1. Company/company

    The page provides information about Gilead Sciences, including its mission, vision, values, history, impact, leadership, and therapeutic areas.

  2. Ethics & Compliance at Gilead Sciences/company/ethics-and-compliance

    Gilead is committed to operating business in line with the highest legal and ethical standards, as a responsible corporate citizen that leads with integrity.

  3. Gilead Sciences: policies/company/policies-and-procedures

    Gilead says it is committed to maintaining ethical standards and has a Code of Ethics, Anti-Bribery and Anti-Corruption, and other corporate policies.

Contact

3 pages
  1. Gilead Sciences: contact us/contact-us

    How to Contact Gilead Sciences: Information for media, investors, grants and to reach the corporate headquarters.

  2. Partnership Requests for Gilead Sciences/contact-us/partnership-request

    Access information on collaboration opportunities for biotech and pharmaceutical companies, nonprofits, community organizations, academic partners and more.

  3. Report an Adverse Event/contact-us/report-an-adverse-event

    $name description

Homepage

1 page
  1. Homepage/

    Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.